Results 41 to 50 of about 3,587 (149)

Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist Cetrorelix with growth inhibition

International Journal of Oncology, 2009
The aim of the present study was to evaluate the expression of receptors for luteinizing hormone-releasing hormone (LHRH) in human specimens of triple-negative breast cancers (TNBC). In addition, we used in vitro and in vivo models of TNBC to investigate if these receptors are suitable targets for the treatment with the LHRH antagonist cetrorelix ...
Buchholz S, Seitz S, Schally AV, Engel JB, Rick FG, Szalontay L, Hohla F, Krishan A, PAPADIA, ANDREA, Gaiser T, Brockhoff G, Ortmann O, Diedrich K, Köster F.   +13 more
openaire   +4 more sources

Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer. [PDF]

Int J Mol Sci
Nayak P, Varani M, Giorgio A, Campagna G, Caserta D, Signore A.   +5 more
europepmc   +1 more source

Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review. [PDF]

J Clin Med
Giorgio A, Varani M, Lauri C, Bentivoglio V, Nayak P.   +4 more
europepmc   +1 more source

Two cases of MACS due to PBMAH associated with an in vivo aberrant response to LHRH treated with leuprolide acetate. [PDF]

Endocrinol Diabetes Metab Case Rep
Branchaud-Croisetière L, Maillet M, St-Jean M.   +2 more
europepmc   +1 more source

The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]

Cancers (Basel)
Sánchez ML, Robinson P, Italia Z, Hoang T, Muñoz M, Coveñas R.   +5 more
europepmc   +1 more source

Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer. [PDF]

NPJ Breast Cancer
Lee H, Kim N, Kim S, Kim JY, Park YH, Ahn HK, Cho J, Kang D, Ahn JS.   +8 more
europepmc   +1 more source

Advancements in Polysaccharide-Based Nanoparticles for the Treatment of Breast Cancer: A Comprehensive Review. [PDF]

Pharmaceuticals (Basel)
Mohanto S, Gowda BHJ, Hani U, Narayana S, Ahmed MG, Fatima F, Paul K.   +6 more
europepmc   +1 more source

A stepwise responsive Au-SS-PEG/Sor/ATP_aptamer/LHRH-MPG^ΔNLS drug delivery vector system for overcoming drug resistance in immunotherapy of hepatocellular carcinoma. [PDF]

Nanoscale Adv
Tong M, Chen G, Dong Y, Pan Y, Xue Y, Li D.   +5 more
europepmc   +1 more source

The Double-Edged Nature of the Gonadotropin-Releasing Hormone Agonist (GnRHa) Long Protocol: A Case of Paradoxical Ovarian Hyperstimulation During the Expected Downregulation Phase. [PDF]

J Clin Med
Nádasdi B, Kovács P, Csajbók ÉA, Wellinger K, Vágvölgyi A, Zádori J.   +5 more
europepmc   +1 more source

Menopause-related side effects in HR+ early breast cancer: insights from clinical practice. [PDF]

Ther Adv Med Oncol
Dimitrijevic M, Calamac M, Djurmez O, Stanic N, Gavrilovic D, Bozovic-Spasojevic I.   +5 more
europepmc   +1 more source